FCC Launches Inquiry into Potential Ratings for Transgender and Gender-Identity ContentApril 24, 2026
Featured CVS Health Denies Coverage for Promising New HIV DrugRogueSeptember 5, 2025 CVS Health, the largest pharmacy benefit manager in the United States, will not cover Gilead Sciences’ Yeztugo, for now. Yeztugo, whose generic…